
At the BT India@100 Summit, Ajay Sahai of FIEO and Agneshwar Sen of EY India raise serious red flags about the fallout of Trump’s 50% tariffs on Indian exports. In conversation with Business Today’s Aabha Bakaya, Sahai estimates that 55–60% of India’s exports to the U.S. will take a hit—though brand contracts and social compliance norms might delay the damage. Sen warns that even zero-tariff sectors like pharma are under threat, with Trump signalling 250% penalties unless firms shift to U.S.-based manufacturing. While India eyes diversification and FTAs with the UK and EU, the short-term impact could be severe. A must-watch session on how India Inc. is bracing for disruption.